Impact of hormonal contraceptives on cervical Th17 phenotype and function in adolescents: Results from a randomized cross-over study comparing long-acting injectable norethisterone oenanthate (NET-EN), combined oral contraceptive pills, and combined contraceptive vaginal rings.
Adolescents in sub-Saharan Africa are at risk for HIV infection and unintended pregnancies. Observational studies suggest that injectable hormonal contraceptives (HC) increase HIV risk, although their effects on genital inflammation, particularly HIV-susceptible Th17 cells, are unknown. In a randomized cross-over study, the effect of injectable norethisterone oenanthate (NET-EN), combined contraceptive vaginal rings (CCVR; NuvaRing®), and combined oral contraceptive pills (COCPs) on cervical Th17 cells and cytokines were compared. Adolescents (n=130; 15-19 years), randomized 1:1:1 to NET-EN, CCVR, or COCPs for 16-weeks, subsequently crossed-over to another HC for 16-weeks. Estrogen (E2), follicular stimulating hormone (FSH), and luteinizing hormone (LH) were measured. CCR5, HLA-DR and CD38 expression by cervical cytobrush-derived CD4+ T cells was assessed by FACS. Th17 cells were defined as CCR6+CCR10-. Cervicovaginal Th17-related cytokines were measured by Luminex. CCVR use for the first 16-weeks was associated with reduced Th17 frequencies and lower FHS and LH concentrations compared to NET-EN/COCPs, with FHS concentrations and Th17 frequencies correlating significantly. However, Th17-related cytokine concentrations (IL-21, IL-1β, TNF-α, IFN-γ) and CCR5+HLA-DR+CD38+ Th17 frequencies were significantly higher in CCVR than NET-EN/COCP. At cross-over, CCVR users changing to COCPs or NET-EN did not resolve activation or cytokines, although switching from COCP to CCVRs increased cytokine concentrations. CCVR use altered endogenous hormone levels and associated cervical Th17 cell frequencies to greater extent than NET-EN/COCPs, although Th17 cells were more activated and Th17-related cytokine concentrations were elevated. While CCVRs may impact HIV risk by regulating Th17 numbers, increased activation/inflammation may balance any risk gains.